Ulrike Bacher Selected Research

Ulrike Bacher Research Topics

Disease

38	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2022 - 04/2005
24	Neoplasms (Cancer) 01/2022 - 01/2009
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 01/2010
12	Residual Neoplasm 01/2022 - 01/2008
12	Leukemia 10/2021 - 05/2007
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 04/2005
11	Multiple Myeloma 01/2019 - 07/2009
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 04/2005
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2009
6	Lymphoma (Lymphomas) 02/2021 - 10/2015
6	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 02/2009
6	Hematologic Neoplasms (Hematological Malignancy) 11/2019 - 08/2008
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 10/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2022 - 11/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 05/2022 - 01/2010
4	Pathologic Complete Response 01/2022 - 01/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2022 - 12/2013
3	Fever (Fevers) 02/2021 - 01/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 05/2011
3	Bronchiolitis Obliterans Syndrome 10/2015 - 08/2008
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 04/2022 - 01/2011
2	Blast Crisis (Blast Phase) 10/2020 - 03/2010
2	Thrombocytosis (Thrombocythemia) 04/2019 - 05/2013
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 12/2015
2	Hodgkin Disease (Hodgkin's Disease) 10/2016 - 01/2011
2	Refractory Anemia 05/2013 - 06/2007
2	Acute Promyelocytic Leukemia 12/2011 - 05/2007
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2011 - 05/2010
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Transthyretin-Related Hereditary Amyloidosis 10/2021
1	Amyloidosis 10/2021
1	COVID-19 06/2021
1	Pulmonary Edema 02/2021
1	Exanthema (Rash) 02/2021
1	Diarrhea 02/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Neutropenia 12/2020
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 11/2020
1	monosomy Chromosome 7 01/2020
1	Cytokine Release Syndrome 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2019

Drug/Important Bio-Agent (IBA)

6	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2009
4	Chimeric Antigen ReceptorsIBA 05/2022 - 01/2020
4	Busulfan (Busulfex)FDA Link 02/2022 - 08/2008
4	Melphalan (Alkeran)FDA LinkGeneric 02/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 04/2019 - 06/2011
4	Biological ProductsIBA 08/2014 - 01/2010
4	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 03/2010
3	fludarabineIBA 11/2021 - 01/2013
3	S63845IBA 07/2021 - 11/2019
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 08/2008
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2010
3	AntigensIBA 05/2013 - 01/2011
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2012 - 01/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 02/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 11/2019
2	trametinibIBA 02/2021 - 11/2019
2	Immunoglobulin G (IgG)IBA 11/2020 - 10/2015
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2012
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 06/2017
2	EpitopesIBA 01/2016 - 05/2011
2	Phosphotransferases (Kinase)IBA 10/2010 - 06/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Prealbumin (Transthyretin)IBA 10/2021
1	fms-Like Tyrosine Kinase 3IBA 07/2021
1	PTC596IBA 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	idelalisibIBA 01/2021
1	Darbepoetin alfa (Aranesp)FDA Link 12/2020
1	isocitric acid (isocitrate)IBA 10/2020
1	Vitamin D FDA LinkGeneric 10/2020
1	AcidsIBA 10/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	InterleukinsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Bendamustine Hydrochloride FDA Link 12/2019
1	siremadlinIBA 11/2019
1	plerixafor FDA Link 01/2019

Therapy/Procedure

44	Stem Cell Transplantation 06/2022 - 08/2008
24	Therapeutics 05/2022 - 05/2007
23	Cell Transplantation 11/2022 - 01/2012
16	Transplantation 04/2022 - 09/2010
15	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2010
10	Drug Therapy (Chemotherapy) 06/2022 - 12/2011
8	Homologous Transplantation 11/2021 - 09/2010
4	Hematopoietic Stem Cell Mobilization 01/2020 - 01/2018
4	Induction Chemotherapy 01/2020 - 07/2006
3	Autologous Transplantation 01/2020 - 01/2018
1	Donor Selection 03/2022
1	MDC protocol 01/2022
1	Treatment Delay 10/2021
1	Precision Medicine 06/2021